Sign Out
Hypersensitivity to methylphenidate or to any of the excipients.
Anxiety, tension.
Agitation.
Hyperthyroidism.
Pre-existing cardiovascular disorders including severe hypertension, angina, arterial occlusive disease; heart failure, hemodynamically significant congenital heart disease, cardiomyopathies, myocardial infarction, potentially life-threatening arrhythmias and channelopathies (disorders caused by the dysfunction of ion channels).
During treatment with monoamine oxidase (MAO) inhibitors, or within a minimum of 2 weeks of discontinuing those drugs, due to risk of hypertensive crisis (see INTERACTIONS).
Glaucoma.
Phaeochromocytoma.
Diagnosis or family history of Tourette's syndrome.
